Fibroblast growth factor 23 and symmetric dimethylarginine concentrations in geriatric cats

BACKGROUND: Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that is increased in azotemic cats with chronic kidney disease (CKD) and predictive of the onset of azotemia in older cats. The introduction of symmetric dimethylarginine (SDMA) as a biomarker of glomerular filtration rate has...

Descripción completa

Detalles Bibliográficos
Autores principales: Sargent, Hannah J., Jepson, Rosanne E., Chang, Yu‐mei, Biourge, Vincent C., Bijsmans, Esther S., Elliott, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872607/
https://www.ncbi.nlm.nih.gov/pubmed/31568615
http://dx.doi.org/10.1111/jvim.15590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872607/
https://www.ncbi.nlm.nih.gov/pubmed/31568615
http://dx.doi.org/10.1111/jvim.15590

Ejemplares similares